Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement

(2013) Frederik E. Stuurman et al.   CLINICAL PHARMACOKINETICS

Why Clinical Modulation of Efflux Transport at the Human Blood–Brain Barrier Is Unlikely: The ITC Evidence-Based Position

(2013) J C Kalvass et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin

(2012) Sara K. Quinney et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

(2012) Jeroen J.M.A. Hendrikx et al.   INTERNATIONAL JOURNAL OF CANCER

Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity

(2012) Rafid Salim Jabir et al.   PHARMACOGENOMICS

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

(2011) Hongju Wu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

(2010) Stijn L. W. Koolen et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cytochrome P450-mediated metabolism in the human gut wall

(2010) Kirstin Thelen et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice

(2009) Hongchi Jiang et al.   CANCER INVESTIGATION

Absence of Both Cytochrome P450 3A and P-glycoprotein Dramatically Increases Docetaxel Oral Bioavailability and Risk of Intestinal Toxicity

(2009) R. A.B. van Waterschoot et al.   CANCER RESEARCH

Coadministration of Ritonavir Strongly Enhances the Apparent Oral Bioavailability of Docetaxel in Patients with Solid Tumors

(2009) R. L. Oostendorp et al.   CLINICAL CANCER RESEARCH

Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel

(2009) S L W Koolen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects

(2009) Alessandra di Masi et al.   MOLECULAR ASPECTS OF MEDICINE

Animal models and intestinal drug transport

(2008) Hartmut Glaeser et al.   Expert Opinion on Drug Metabolism & Toxicology